Pharmaceutical Technology

DECEMBER 19, 2022

However, stopping nucleation and growth is challenging and often involves the use of biohazardous substances. The second is the “top-down” approach during which an initial micrometre-sized product is processed to reduce its size down into the nano-range using bead milling. Further scaling-up is delicate and laborious.

Production 130

Production Bioavailability Biohazard Biohazard 130

Advarra

AUGUST 31, 2022

Institutional biosafety committees (IBCs) frequently receive questions about the proper methodology for preparing a syringe for transport from a drug room or pharmacy to the clinic where the injection will be administered. The post Safe Sharps Handling When Dispensing Investigational Products appeared first on Advarra.

Production 52

Production Biohazard Biohazard Containment 52

Advarra

OCTOBER 26, 2023

Ensuring the safe and secure transport of investigational products (IP) is a core part of biosafety. This critical task requires meticulous planning and rigorous procedures to avoid any hazards potentially arising during the journey of an IP from the controlled environment of a pharmacy or preparation room to its destination.

Production 52

Production Containment Biohazard Biohazard 52

Advarra

JULY 28, 2022

Biosafety cabinets (BSCs) protect the product as well as the user and the environment. The hood also blows sterile (HEPA filtered air) from the top down towards the work surface to protect the product from contamination with non-sterile ambient room air. . What is a Biosafety Cabinet? They operate under negative air pressure (i.e.,

Contamination 52

Contamination Biohazard Biohazard Production 52